Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms.

PURPOSE To determine the correlation between the degree of plaque enhancement with contrast agent microbubbles and clinical symptoms in patients with carotid atherosclerotic plaque. MATERIALS AND METHODS The study was approved by the hospital ethical committee, and informed consent was obtained from all patients. One hundred four patients (83 men: mean age, 64 years +/- 9 [standard deviation]; 21 women: mean age, 61 years +/- 10) with carotid plaques were studied with standard and contrast material-enhanced ultrasonography (US). Contrast enhancement in the plaque was evaluated with visual interpretation and quantitative analysis. RESULTS Among the 104 patients, 35 (34%) had transient ischemic attack and/or cerebrovascular ischemic stroke. Plaque enhancement was found in 28 (80%) of 35 symptomatic patients and in 21 (30%) of 69 asymptomatic patients (P < .001). Enhanced intensity in the plaque (13.9 dB +/- 6.4) and the ratio of enhanced intensity in the plaque to that in the lumen of the carotid artery (0.54 +/- 0.23) in symptomatic patients were significantly greater than those in asymptomatic patients (8.8 dB +/- 5.2 [P < .001] and 0.33 +/- 0.19 [P < .001], respectively). Sensitivity and specificity were 74% and 62%, respectively, for enhanced intensity in the plaque (cutoff value, 10.0 dB) and 74% and 75%, respectively, for ratio of enhanced intensity in the plaque to that in the lumen of the carotid artery (cutoff value, 0.46). CONCLUSION Symptomatic patients had more intense contrast agent enhancement in the plaque than asymptomatic patients, suggesting that contrast-enhanced carotid US may be used for plaque risk stratification.

[1]  Jie Tang,et al.  Contrast‐Enhanced Ultrasonography for Assessment of Tumor Vascularity in Hepatocellular Carcinoma , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[2]  M. Quiñones,et al.  Microvascular Structural Correlates of Myocardial Contrast Echocardiography in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: Implications for the Assessment of Myocardial Hibernation , 2002, Circulation.

[3]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[4]  Feng Yan,et al.  BR1: A New Ultrasonographic Contrast Agent Based on Sulfur Hexafluoride-Filled Microbubbles , 1995, Investigative radiology.

[5]  Antonio Colombo,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. , 2003, Circulation.

[6]  J. Hodgson,et al.  Intracoronary ultrasound imaging: correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty. , 1993, Journal of the American College of Cardiology.

[7]  S. Feinstein,et al.  Effect of contrast enhancement on measurement of carotid artery intimal medial thickness , 2004 .

[8]  M. Naghavi,et al.  Vulnerable Atherosclerotic Plaque: A Multifocal Disease , 2003, Circulation.

[9]  Roberto Chiesa,et al.  Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. , 2008, Journal of the American College of Cardiology.

[10]  A. Naylor,et al.  Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. , 2007, Journal of vascular surgery.

[11]  Gian Luigi Lenzi,et al.  Detection of Carotid Adventitial Vasa Vasorum and Plaque Vascularization With Ultrasound Cadence Contrast Pulse Sequencing Technique and Echo-Contrast Agent , 2007, Stroke.

[12]  S. Feinstein,et al.  Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. , 2006, Journal of the American College of Cardiology.

[13]  S. Feinstein,et al.  Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. , 2004, The American journal of cardiology.

[14]  Steven B. Feinstein,et al.  Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? , 2007, Vascular medicine.

[15]  B. Nordestgaard,et al.  Ultrasonic Echolucent Carotid Plaques Predict Future Strokes , 2001, Circulation.

[16]  D. Bokor,et al.  Diagnostic efficacy of SonoVue. , 2000, The American journal of cardiology.

[17]  Rolf Kern,et al.  Characterization of Carotid Artery Plaques Using Real-time Compound B-mode Ultrasound , 2004, Stroke.

[18]  Juan J. Badimon,et al.  Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability , 2004, Circulation.

[19]  Gieri Cathomas,et al.  Arterial Neovascularization and Inflammation in Vulnerable Patients: Early and Late Signs of Symptomatic Atherosclerosis , 2004, Circulation.

[20]  D. Cosgrove,et al.  Angiogenesis imaging--ultrasound. , 2003, The British journal of radiology.

[21]  S. Feinstein,et al.  The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. , 2004, American journal of physiology. Heart and circulatory physiology.

[22]  P R Bell,et al.  Angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology , 1999, Journal of vascular surgery.

[23]  Robert F Mattrey,et al.  Carotid arteries: contrast-enhanced US angiography--preliminary clinical experience. , 2004, Radiology.

[24]  Stefan Puchner,et al.  Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients. , 2008, Radiology.